President Donald Trump on Thursday (05/02) unveiled the website TrumpRx.gov, which offers to consumers access to discounted prescription medicines, as Trump’s efforts to lower drug prices in US.
Through the website, patients will be able to access large discounts on many of the most popular and highest-priced medicines in the country, paying prices in line with the lowest paid by other developed nations (known as the most-favored-nation, or MFN, price).
According to White House announcement:
- This launch features drugs made by the first five manufacturers to reach MFN pricing deals with the Trump Administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer.
- Additional drugs from other companies that have signed MFN pricing deals will be made available through TrumpRx.gov in the coming months.
- TrumpRx.gov provides patients with access to a world-class experience for accessing deep discounts on the medicines they need. Depending on the manufacturer of a given drug, patients with valid prescriptions will be able to access savings through user-friendly coupons that can be printed or downloaded onto their phones or through channels set up by the manufacturer and integrated into TrumpRx.gov.
DELIVERING LOWER COSTS ON THE MOST POPULAR DRUGS: As of today, patients purchasing directly through TrumpRx.gov will be able to see massive price reductions on 40 of the most popular and expensive branded medicines in the nation. Select examples include:
- Historic price reductions for Americans on the two drugs with the highest annual expenditures in the United States, which help adults struggling with diabetes, heart disease (Ozempic and Wegovy only), obesity, and other conditions.
- The monthly prices of Ozempic and injectable Wegovy will fall from $1,028 and $1,349, respectively, to an average price of $350 and as low as $199, depending on dosage strength.The monthly price of the Wegovy pill will fall from $1,349 to as low as $149, depending on dosage strength.
- The monthly price of Zepbound and will fall from $1,088 to an average price of $346 and as low as $299, depending on dosage strength.
- Massive savings on some of the most commonly used fertility medications in the country to help families grow. Many patients struggling with infertility pay for their medicines out-of-pocket, meaning they will stand to save more than $2,000 per cycle of fertility drugs, on average.
- Gonal-F, one of the most commonly-used fertility drugs, will see its price reduced to as low as $168 per pen, depending on dosage strength.
- The price of Cetrotide, another commonly used fertility medicine, will drop from $316 to $22.50.
- The price of Ovidrel will fall from $251 to $84.
- Discounts on numerous other high-cost drugs, including:
- Bevespi Aerosphere, an inhaler used to treat chronic obstructive pulmonary disease (COPD), will be discounted from $458 to $51.
- Airsupra, an inhaler used to treat asthma symptoms and attacks, will see a price drop from $504 to $201.
- Eucrisa, a topical ointment for atopic dermatitis, will be discounted from $792 to $158.
- Insulin Lispro will be available for as low as $25 per month.
- Duavee, a medication used to treat hot flashes and osteoporosis, will see its price cut from $202 to $30.
About the Author
